Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-01-04 @ 9:06 AM
Study NCT ID:
NCT02988960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-08
First Post:
2016-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2016-12-08
First Submit QC Date:
None
Study First Post Date:
2016-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-08
Last Update Post Date Type:
ACTUAL